Amgen, GlaxoSmithKline and Roche are some of the major research laboratories that are sharing confidential information with anti-doping officials at this year's games, according to the AP.
“If you want to predict the future of doping it’s essential that you have collaborations with the pharmas,” said Olivier Rabin, Science Director of the World Anti-Doping Authority (WADA), overseer of Olympic testing standards.
The Biotech Industry Organization, which represents most biotech drug makers, signed an agreement with WADA in 2011. Information is voluntarily shared about drugs that are being made that might be used by competitive athletes.
"A lot of what dopers are looking for is under the radar. They’re looking for drugs that were terminated and that enforcement agencies don’t know about yet," Mark Luttman, who coordinates Glaxo’s anti-doping program with WADA, told the AP.
No comments:
Post a Comment
Thanks for your comment!